Company Profiles

driven by the PitchBook Platform

Amplyx

Description

Developer of broad-spectrum antifungal agents designed to treat invasive fungal infections. The company's small-molecule therapy, APX001, uses both intravenous and oral formulations to address the need for treatment in both the hospital setting and continued convenient treatment after discharge from hospital, enabling patients undergoing chemotherapy and other immunosuppressive treatments, with compromised immune systems, to get proper treatment for life-threatening invasive fungal infections due to candida, aspergillus and rare molds.

2006

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$49.2M

Latest Deal Amount

$53.7M

Total Amount Raised

Description

Developer of broad-spectrum antifungal agents designed to treat invasive fungal infections. The company's small-molecule therapy, APX001, uses both intravenous and oral formulations to address the need for treatment in both the hospital setting and continued convenient treatment after discharge from hospital, enabling patients undergoing chemotherapy and other immunosuppressive treatments, with compromised immune systems, to get proper treatment for life-threatening invasive fungal infections due to candida, aspergillus and rare molds.

Website:

www.amplyx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

12730 High Bluff Drive Suite 160 San Diego, CA 92130United States +1 (858) 345-1755
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Amplyx's full profile, request a free trial.

    Amplyx Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Amplyx Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Amplyx Investors (15)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    3x5 Special Opportunity PartnersVenture CapitalMinority000 0000000 0000
    Ariel Southeast Angel PartnersAngel GroupMinority000 0000000 0000
    BiobritVenture CapitalMinority000 0000000 0000
    BioMed VenturesCorporate Venture CapitalMinority000 0000000 0000
    Golden SeedsAngel GroupMinority000 0000000 0000
    3x5 Special Opportunity Partners Venture Capital
    Ariel Southeast Angel Partners Angel Group
    Biobrit Venture Capital
    BioMed Ventures Corporate Venture Capital
    Golden Seeds Angel Group

    Amplyx Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Ciara Kennedy Ph.DPresident, Chief Executive Officer and Board Member
    Karen Shaw Ph.DChief Scientific Officer
    Susan DubéVice President of Business Development and Administration
    Pamela WedelVice President of Clinical Operations
    Elizabeth Gordon Ph.DVice President, Regulatory Affairs
    Ciara Kennedy Ph.D President, Chief Executive Officer and Board Member
    Karen Shaw Ph.D Chief Scientific Officer
    Susan Dubé Vice President of Business Development and Administration
    Pamela Wedel Vice President of Clinical Operations
    Elizabeth Gordon Ph.D Vice President, Regulatory Affairs

    Amplyx Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Edward MathersNew Enterprise AssociatesPartner000 0000
    Elaine Heron Ph.DAmplyxBoard Member000 0000
    Michael GreyAmplyxExecutive Chairman of the Board of Director000 0000
    Niall O'Donnell Ph.DRiverVest Venture PartnersManaging Director000 0000
    Paul Grint MDSelfBoard Member000 0000
    Edward Mathers Partner New Enterprise Associates
    Elaine Heron Ph.D Board Member Amplyx
    Michael Grey Executive Chairman of the Board of Director Amplyx
    Niall O'Donnell Ph.D Managing Director RiverVest Venture Partners
    Paul Grint MD Board Member Self
    Request full access to PitchBook